Background Genitourinary syndrome of menopause (GSM) is a widespread condition with a
great impact on quality of life and self-image. Aim We aimed to systematically review the …

Vulvovaginal atrophy (VVA) is a chronic progressive disease involving the female genital
apparatus and lower urinary tract. This condition is related to hypoestrogenism consequent …

Vulvovaginal atrophy (VVA) is a chronic progressive condition that involves the genital and
lower urinary tracts, related to the decrease of serum estrogenic levels when menopause …

Genitourinary syndrome of menopause (GSM) is a term used to define a compilation of signs
and symptoms arising from decreased estrogenic stimulation of the vulvovaginal and lower …

In recent years, LASER has been introduced as a minimally invasive treatment for a broad
range of vaginal and vulvar symptoms and diseases. However, the efficacy and safety of …

Background Genitourinary syndrome of menopause (GSM) can have a great impact on the
quality of life (QOL), and affects between 53.8% and 90% of postmenopausal women. The …

Objective: To compare the efficacy of fractional CO2 laser therapy with topical estrogen
therapy for the treatment of postmenopausal genitourinary syndrome of menopause …

Background Genitourinary syndrome of menopause (GSM) negatively affects sexual
function and quality of life. Techniques like laser and radiofrequency are being used to …

Objective: To review the short-term effects and safety of vulvovaginal fractional microablative
CO2 laser therapy on atrophy symptoms using validated questionnaires pre-and …

Women who have previously received radiotherapy (RT) for gynecologic cancer often suffer
from vaginal fibrosis and stenosis. The success of “non-ablative” laser therapy for …